GLP-1 agonists have become popular treatments for weight loss and type 2 diabetes, and newer studies suggest other health benefits as well. Findings from experiments on mice, published in the Journal of Virology, suggest ...
Jul 9, 2026
0
3
Despite substantial weight loss, most obesity drugs such as Wegovy and Mounjaro do not meaningfully improve quality of life, and few show cardiovascular benefits at one year, according to an analysis of the latest evidence ...
Jul 8, 2026
0
66
Higher socioeconomic status is not associated with equal reductions in rates of type 2 diabetes and obesity across all racial and ethnic groups in the United States, according to a new study published July 8, 2026, in the ...
Jul 8, 2026
0
4
Chronic kidney disease (CKD) is common, largely silent and serious. Most people who have the condition do not realize they have it, while it sharply raises the risk of heart attacks, strokes, kidney failure and early death. ...
Jul 8, 2026
0
6
People with severe obesity who exercise regularly have healthier blood vessels and lower inflammation than those who rely on medication alone, a new study from the University of Copenhagen shows.
Jul 8, 2026
0
6
Obesity rates among U.S. adults and children rose sharply in recent years, and by 2023, 40% of adults and 20% of youth met the criteria for obesity, according to new, independent research published in Circulation.
Jul 8, 2026
0
8
Allan-Herndon-Dudley syndrome is a rare congenital disease of thyroid metabolism. It occurs in approximately 1 out of every 70,000 male newborns, and its effects are devastating. Since early 2025, a medication has been approved ...
Jul 8, 2026
0
3
The presence of certain bacteria in the gut microbiota, and fluctuations in a person's metabolism, can be seen in people who go on to develop type 2 diabetes years later. This has been shown in a large Swedish study led by ...
Jul 7, 2026
0
14
A major new study, published in The Lancet Diabetes & Endocrinology, has shown that cortisol levels in patients with adrenal tumors are far less stable than previously assumed. The study also found that those in whom cortisol ...
Jul 7, 2026
0
5
A research team at The Hong Kong Polytechnic University (PolyU) has developed Hong Kong's first "AI Agent for Precision Diabetes Management—PIPE-AI" (AI Agent), designed specifically for Asian populations, together with a ...
Jul 7, 2026
0
5
